These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11049992)

  • 61. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Rezaei N; Mahmoudi E; Aghamohammadi A; Das R; Nichols KE
    Br J Haematol; 2011 Jan; 152(1):13-30. PubMed ID: 21083659
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The value of DNA storage and pedigree analysis in rare diseases: a 17-year-old boy with X-linked lymphoproliferative disease (XLP) caused by a de novo SH2D1A mutation.
    Overwater E; Smulders Y; van der Burg M; Lombardi MP; Meijers-Heijboer HE; Kuijpers TW; Houweling AC
    Eur J Pediatr; 2014 Dec; 173(12):1695-8. PubMed ID: 24723092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
    Nagy N; Klein E
    Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription.
    Parolini O; Weinhäusel A; Kagerbauer B; Sassmann J; Holter W; Gadner H; Haas OA; Knapp W
    Immunogenetics; 2003 May; 55(2):116-21. PubMed ID: 12709835
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
    Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
    EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
    Howie D; Sayos J; Terhorst C; Morra M
    Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular and immunological basis of X-linked lymphoproliferative disease.
    Latour S; Veillette A
    Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disease-causing SAP mutants are defective in ligand binding and protein folding.
    Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
    Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
    [TBL] [Abstract][Full Text] [Related]  

  • 71. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
    Veillette A; Pérez-Quintero LA; Latour S
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
    Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
    Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [X-linked lymphoproliferative syndrome (XLP syndrome): from clinic to gene].
    Stéphan JL
    Arch Pediatr; 2000 Nov; 7(11):1205-11. PubMed ID: 11109949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.
    Wu L; Yang F; Wang J; Yang F; Liang M; Yang H
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1873. PubMed ID: 35092357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
    Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
    Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.
    Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V
    J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
    Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
    Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
    [TBL] [Abstract][Full Text] [Related]  

  • 78. X-linked lymphoproliferative disease: pathology and diagnosis.
    Maia DM; Garwacki CP
    Pediatr Dev Pathol; 1999; 2(1):72-7. PubMed ID: 9841710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection.
    Strahm B; Rittweiler K; Duffner U; Brandau O; Orlowska-Volk M; Karajannis MA; Stadt Uz; Tiemann M; Reiter A; Brandis M; Meindl A; Niemeyer CM
    Br J Haematol; 2000 Feb; 108(2):377-82. PubMed ID: 10691868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.